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22q11.2 microdeletions result in specific cognitive
deficits and schizophrenia. Analysis of Df(16)A+/
mice, which model this microdeletion, revealed
abnormalities in the formation of neuronal dendrites
and spines, as well as altered brain microRNAs.
Here, we show a drastic reduction ofmiR-185, which
resides within the 22q11.2 locus, to levels more than
expected by a hemizygous deletion, and we demon-
strate that this reduction alters dendritic and spine
development. miR-185 represses, through an evolu-
tionarily conserved target site, a previously unknown
inhibitor of these processes that resides in the Golgi
apparatus and shows higher prenatal brain expres-
sion. Sustained derepression of this inhibitor after
birth represents the most robust transcriptional
disturbance in the brains of Df(16)A+/ mice and
results in structural alterations in the hippocampus.
Reduction of miR-185 also has milder age- and
region-specific effects on the expression of some
Golgi-related genes. Our findings illuminate the
contribution of microRNAs in psychiatric disorders
and cognitive dysfunction.
INTRODUCTION
The identification of a widespread role of chromosomal microde-
letions and microduplications (copy number variants or CNVs) in
determining susceptibility to psychiatric disorders such as
schizophrenia (SCZ), as well as neurodevelopmental disorders
such as autism and intellectual disability, represents a shift in
our understanding of the genetic architecture of these disorders
and highlights the pervasive contribution of rare and highly pene-
trant structural mutations (Karayiorgou et al., 1995; Morrow,
2010; Rodriguez-Murillo et al., 2012). Along these lines, a strong262 Cell 152, 262–275, January 17, 2013 ª2013 Elsevier Inc.link has been established between microdeletions in chromo-
some 22q11.2, cognitive dysfunction and psychiatric disorders,
especially SCZ (Karayiorgou et al., 1995, 2010; Xu et al., 2008).
Understanding how the genes disrupted by this deletion
contribute to the ensuing psychiatric and cognitive phenotypes
will provide important mechanistic insights and guide analysis
of other pathogenic mutations (Arguello and Gogos, 2006,
2010, 2012; International Schizophrenia Consortium, 2008;
Karayiorgou et al., 2010).
By using chromosomal engineering, we generated a mouse
model carrying a hemizygous 1.3 Mb chromosomal deficiency
on mouse chromosome 16 (Df(16)A), which is syntenic to the
1.5 Mb 22q11.2 microdeletion (Stark et al., 2008). Analysis of
Df(16)A+/ mice showed abnormalities in dendritic morphogen-
esis and formation of dendritic spines of hippocampal pyramidal
neurons both in culture and in vivo (Mukai et al., 2008; Stark et al.,
2008). Such changes may account, at least in part, for the
regional decreases in gray matter volumes observed in some
22q11.2 deletion carriers (Bearden et al., 2009; Chow et al.,
2002) and may ultimately lead to altered information processing.
Analysis of the Df(16)A+/ strain also provided compelling
evidence that the 22q11.2microdeletion results in abnormal pro-
cessing of brain microRNAs (miRNAs), a class of small noncod-
ing RNAs that regulate the stability and translation of mRNAs
(Fineberg et al., 2009; Kosik, 2006; Schratt, 2009; Xu et al.,
2010), implicating miRNA dysregulation in the pathogenesis of
psychiatric disorders and cognitive dysfunction. One gene dis-
rupted by the 22q11.2 microdeletion is DGCR8, a component
of the ‘‘microprocessor’’ complex that is essential for miRNA
production (Tomari and Zamore, 2005).Dgcr8 haploinsufficiency
results in the downregulation of a specific subset of mature
miRNAs and contributes to alterations found in Df(16)A+/ mice
(Fe´nelon et al., 2011; Stark et al., 2008). miRNA dysregulation
likely accounts for a fraction of the transcript misexpression in
the brains of Df(16)A+/ mice (Stark et al., 2008), but direct
targets have not been reported. Here, we highlight an important
component of this dysregulation and identify a previously un-
characterized gene with prenatal expression bias as a major
Figure 1. Drastic Reduction of mir-185 Expression in Df(16)A+/ Mice
(A) Schematic diagram showing the 1.5 Mb 22q11.2 critical region and the syntenic mouse locus. The 1.5 Mb deletion is mediated by low copy repeat sequences
LCR-A and LCR-B (illustrated as black boxes). Dgcr8 andmiR-185 (hosted in the intron of the 22orf25 gene in human and the D16H22S680E gene in mouse) are
highlighted in red. Chr22, chromosome 22; Chr16, chromosome 16.
(B) Expression ofmiR-185mRNA inHPC and cortex as shown by in situ hybridization in coronal brain sections using an antisensemiR-185 probe. An antisenseU6
probe and a scramble probe were used as positive and negative controls, respectively. Images were taken at either 43 (left) or 103 (right) magnification.
(C–E) miR-185 expression levels in HPC (C) or PFC (D) of Df(16)A+/ (n = 7 for mutant, n = 9 for WT) and in HPC (E) of Dgcr8+/ (n = 10 for mutant and WT), as
assayed by qRT-PCR. Expression levels in mutant mice were normalized to their respective WT littermates.
Results are expressed as mean ±SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 (Student’s t test). See also Figure S1.miRNA target mediating the effects of the 22q11.2 microdeletion
on neuronal maturation and connectivity.
RESULTS
A Drastic Reduction ofmiR-185 Levels in
Df(16)A+/ Mice
Studies in the Df(16)A+/ mouse strain have shown that the
22q11.2 microdeletion results in abnormal processing of
a specific subset of brain miRNAs due to the removal of one
copy of the Dgcr8 gene causing a decrease in its expression in
the adult brain (Stark et al., 2008) as well as in early development
(Figure S1A available online). It is noteworthy that, in addition to
Dgcr8, the 22q11.2 microdeletion and the equivalent mouse
deficiency remove one copy of a miRNA gene (miR-185) located
within the minimal 1.5 Mb 22q11.2 critical region (Figure 1A). In
situ hybridization assays indicated that miR-185 is expressed
in several brain regions such as hippocampus (HPC) and cortex
(Figure 1B). qRT-PCR analysis showed that expression of
miR-185 is dramatically reduced by 70%–80% in both HPC(p < 106) and prefrontal cortex (PFC; p < 1011) of adult Df(16)
A+/ mice as compared to wild-type (WT) littermates (Figures
1C and 1D). This reduction was also observed at earlier develop-
mental stages (embryonic day 17 [E17] and postnatal day 6 [P6])
(Figure S1B). miR-185 also showed a more modest decrease in
Dgcr8+/ mice (20% in HPC; p < 0.05; Figure 1E), suggesting
that the severe reduction of mature miR-185 expression in
Df(16)A+/mice may be due to a combined effect of hemizygos-
ity of the miR-185 gene and impaired maturation of the pri-mir-
185 transcript produced from the remaining copy, due to the
reduction in Dgcr8 levels. Such a large reduction in expression
of a resident gene to levels greater than expected by the 50%
decrease in gene dosage is unique among genes affected by
the 22q11.2 microdeletion.
A Primary Transcriptional Consequence of 22q11.2
Genomic Loss
Previous microarray analysis of adult Df(16)A+/ mice revealed
genome-wide alterations of transcriptional programs in the
HPC and PFC (Stark et al., 2008). We extended expressionCell 152, 262–275, January 17, 2013 ª2013 Elsevier Inc. 263
Figure 2. 2310044H10Rik Is Robustly Upregulated in the Brain of Df(16)A+/ Mice
(A) Changes in gene expression in the PFC (upper panel) or HPC (lower panel) ofDf(16)A+/ andWT littermate control mice at E16, P6, and adulthood (n = 10 each
group). Volcano plot of the p values and the corresponding relative expression of each gene are shown. Light blue dots indicate genes within Df(16)A deficiency,
light green dots indicate upregulated miRNA-containing transcripts, and red dots indicate probe sets representing Mirta22.
(B) Top ten protein-encoding genes that show significant upregulation in the PFC (upper panel) or HPC (lower panel) of Df(16)A+/ andWT littermate mice at E16,
P6, and adulthood. Mirta22 is highlighted in red.
(legend continued on next page)
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profile analysis of these two brain regions to two earlier develop-
mental stages, E17 and P6. Only one gene, 2310044H10Rik, was
consistently significantly upregulated (in at least two of the three
developmental stages examined and in at least one of the two
brain areas tested). Indeed, 2310044H10Rik was among the
top upregulated genes in both postnatal stages examined
(Figures 2A and 2B). Notably, no significant difference in
2310044H10Rik expression was found in either frontal cortex
or HPC at E17 (Figures 2A and 2B). Importantly, there is no
known miRNA within or surrounding this genomic locus, sug-
gesting that the upregulation is not due to impaired processing
of overlapping pri-miRNA transcripts.
In independent experiments, we attempted to distinguish
primary versus secondary gene targets of the 22q11.2 microde-
letion by looking for genes whose expression changes in oppo-
site direction as a result of genomic losses or gains in this locus.
Such genes are likely to represent primary targets and direct
transcriptional readouts of the underlying copy number imbal-
ances (Chahrour et al., 2008). We compared the PFC and HPC
gene expression profiles in mice carrying a deletion or duplica-
tion at the 22q11.2 syntenic mouse locus using as reference
compound heterozygous mice balanced for copy number
(see Extended Experimental Procedures; Figure S2). We identi-
fied a number of inversely altered transcripts in either PFC or
HPC (p < 0.001; Extended Experimental Procedures; Table
S1), in addition to the transcripts from the 22q11.2 region. As
expected, the majority of the identified transcripts are pri-
miRNA forms. Only 12 transcripts were significantly misregu-
lated in a reciprocal manner in both PFC and HPC (Table S2).
Among them, 2310044H10Rik is the only gene with protein-
coding potential.
Taken together, our expression profiling highlighted themisre-
gulation of 2310044H10Rik as a major consequence of the
22q11.2 genomic imbalances at the transcriptome level. We
confirmed the pattern of 2310044H10Rik upregulation in both
PFC and HPC by TaqMan qRT-PCR (PFC: E17, 20%, p = 0.24;
P6, 59%, p < 0.01; Adult, 76%, p < 106; HPC: E17, 20%, p =
0.16; P6, 50%, p < 0.05; Adult, 38%, p < 0.05; Figures 2C and
2D). This analysis revealed a profile of temporal regulation with
prenatal expression bias where levels of 2310044H10Rik rapidly
decline during the first week after birth and remain constantly
low thereafter, as well as a corresponding pattern of misregula-
tion in Df(16)A+/ mice where prenatally elevated expression
persists throughout postnatal and adult life. Increased brain
expression of 2310044H10Rik is recapitulated in Df(16)A+/
primary neurons (Figure 2E).
2310044H10Rik Is a Major Downstream Effector
of miRNA Dysregulation
Notably, 2310044H10Rik mRNA levels were also elevated in
Dgcr8+/ mice (HPC: 30%, p < 0.05; PFC: 24%, p < 0.05; Fig-
ureS3A), suggesting that upregulationmaybedue tomiRNAdys-(C and D) Temporal expression of 2310044H10Rik (Mirta22) in the PFC (C) and HP
for each group).
(E) Increased expression of endogenous 2310044H10Rik (Mirta22) in DIV9 hippoc
each genotype). Expression levels in mutant neurons were normalized to WT ne
Results are expressed as mean ±SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 (Sregulation. Indeed, two miRNA target site prediction programs,
TargetScan (Grimsonet al., 2007) andmirDB (Wang, 2008), report
that the 30 UTR of 2310044H10Rik contains binding sites of
miRNAs shown to be affected in Df(16)A+/ mice by microarray
profiling (Stark et al., 2008). Specifically, mirDB predicted five
such miRNAs with binding sites in the 30 UTR of 2310044H10Rik
including miR-185 and miR-485, whereas TargetScan predicted
13 miRNA sites, including sites for miR-185, miR-485, miR-491,
and miR-224. Notably, both programs predicted sites for miR-
185 and miR-485 (Figure 3A, red rectangles).
Because increased brain expression of 2310044H10Rik is
recapitulated in Df(16)A+/ primary neurons (Figure 2E), we first
used primary neurons to determine whether endogenous
2310044H10Rik expression is actually under the control of
miR-185. To examine the effect of miR-185 overexpression on
2310044H10Rik level, we introduced into primary neuronal
cultures a miRNA precursor mimic (‘‘pre-mir-185’’), which is pro-
cessed intomature miRNA, or a scramble precursor (‘‘prescram-
ble’’) with no homology to the mouse genome, which serves as
a control for nonspecific effects of small RNA expression.
Twenty-four hours posttransfection, there was a decrease in
the levels of 2310044H10Rik in pre-mir-185-transfected neurons
when compared to prescramble-transfected neurons (p < 0.01;
Figure 3B). In a complementary experiment, introduction of an
anti-miR-185 LNA oligo or a scramble control oligo resulted in
an increase of 2310044H10Rik mRNA levels in anti-miR-185-
transfected cells when compared to scramble-transfected cells
(p < 0.05; Figure 3C). Taken together, these results confirm
that 2310044H10Rik expression in primary neurons is under
the repressive control of miR-185. Essentially identical results
were obtained when 2310044H10Rik expression was assayed
in N18 cells (Figures 3D and 3E). Therefore, we used this cell
line to further characterize the miR-185-mediated inhibition.
To test whether the inhibition of miR-185 on 2310044H10Rik
expression is 30 UTR dependent as predicted by TargetScan
and mirDB (see above), 2310044H10Rik 30 UTR-fused luciferase
reporter geneswere cotransfectedwith either pre-mir-185mimic
or prescramble into N18 cells. Although prescramble did not
affect the reporter activity, introduction of pre-mir-185 mimic
led to a dramatic decrease of luciferase activity as compared
to the prescramble control (p < 0.001 for all pre-mir-185 concen-
trations used; Figure 3F). To investigate whether miR-185-medi-
ated repression is specific and operates directly via the two
binding sites predicted by TargetScan (Figure 3A), we engi-
neered luciferase reporters carrying mutated versions of
2310044H10Rik 30 UTR with either individual or both miR-185
binding sites mutated (Mut1:Site 1 mutant; Mut2:Site 2 mutant;
Mut1&2:Site 1 and 2 mutants, see Extended Experimental
Procedures). The pre-mir-185 mimic significantly reduced the
luciferase activity of theWT reporter to25% relative to a control
reporter without 30 UTR, whereas it reduced the luciferase activ-
ities of the Mut1 and Mut2 reporters to 80% (p < 0.01) and 33%C (D) ofDf(16)A+/ andWT littermate mice as monitored by qRT-PCR (n = 9–10
ampal neurons isolated from Df(16)A+/ animals as assayed by qRT-PCR (n = 3
urons.
tudent’s t test). See also Figure S2 and Tables S1 and S2.
Cell 152, 262–275, January 17, 2013 ª2013 Elsevier Inc. 265
Figure 3. miR-185 Directly Targets and Represses 2310044H10Rik
(A) Structure of the 30 UTR of 2310044H10Rik (Mirta22) showing miRNA binding sites predicted by TargetScan or mirDB. Blocks in mouse 2310044H10Rik
(Mirta22) 30 UTR that are highly conserved in rat and human orthologs are shown below themouse 30 UTR. Evolutionary conservation is also assessed by the ‘‘30-
way multiz alignment and conservation analysis’’ in the USCS browser, with conserved blocks indicated by green peaks. miR-185 and miR-485 binding sites
located within the conserved blocks are shown in red.
(B and C) qRT-PCR quantification of endogenous 2310044H10Rik (Mirta22) in DIV7 hippocampal neurons. Expression levels in anti-miR-185-treated and pre-
mir-185-treated neurons were normalized to expression levels under respective controls. (B) Increased expression levels ofMirta22 in neurons transfected with
anti-miR-185 at DIV5 (n = 5, each treatment). (C) Reduced expression levels ofMirta22 in DIV9 hippocampal neurons transfected with pre-mir-185 mimic at DIV7
(n = 3, each treatment).
(D and E) qRT-PCR quantification of endogenous 2310044H10Rik (Mirta22) in N18 cells. Expression levels in pre-mir-185-treated and anti-miR-185-treated cells
were normalized to expression levels under respective controls. (D) Reduced expression levels ofMirta22 in cells transfected with pre-mir-185mimic (n = 3, each
treatment). (E) Upregulation of Mirta22 in cells transfected with an anti-miR-185 LNA oligo (n = 3, each treatment).
(F–H) Repression effects of pre-mir-185, pre-mir-485, and pre-mir-491 onMirta22 30 UTR were examined by a dual-luciferase reporter assay (see Experimental
Procedures). Values areRenilla luciferase levels relative to firefly luciferase levels and normalized to the relative expression levels under prescramble treatment (F
and H) or to the relative expression levels from plasmid with no 30 UTR (G) (n = 3 for each condition). Pre-mir-185 significantly decreases the 2310044H10Rik
(Mirta22) 30 UTR reporter expression over a concentration range of 10–0.01 nM (F). Pre-mir-185-mediated repression on 2310044H10Rik (Mirta22) 30 UTR reporter
expression depends on conserved miRNA binding sites (G). Pre-mir-485 and pre-mir-491 significantly decrease the 2310044H10Rik (Mirta22) 30 UTR reporter
expression (H).
Results are expressed as mean ±SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 (Student’s t test). See also Figure S3 and Table S3.(p < 0.05), respectively (Figure 3G). Notably, the pre-mir-185
mimic could not repress luciferase activity driven from a mutant
reporter where both binding sites are simultaneously disrupted
(Figure 3G). Thus, both miR-185 cognate binding sites have an
impact on the 30 UTR-mediated regulation of 2310044H10Rik
expression, although the site disrupted in the Mut1 reporter
(Site 1) seems to be the major target site via which miR-185
directly exerts its repressive effect.
We further addressed the dependence of 2310044H10Rik 30
UTR reporter repression on the levels of miR-485 or miR-491,
which are also predicted to target binding sites in the 30 UTR of266 Cell 152, 262–275, January 17, 2013 ª2013 Elsevier Inc.the 2310044H10Rik gene. Both of these miRNAs are modestly
downregulated in the HPC of the Df(16)A+/ mice due to Dgcr8
hemizygosity (Figure S3B). The pre-miRNA mimics of either
miRNA modestly but significantly reduced the luciferase activity
of the 30 UTR-fused reporter compared to the prescramble
control (pre-mir-485: 27%, p < 0.05; pre-mir-491: 35%, p <
0.05; Figure 3H). A three-factor ANOVA indicated that all
three miRNAs (miR-185, miR-485, and miR-491) and their inter-
actions have significant impact on the luciferase activity with
the exception of the interaction between miR-485 and miR-491
(Table S3).
Taken together, these findings suggest that the persistent
elevation of 2310044H10Rik levels observed in Df(16)A+/ mice
is likely the result of the combined hemizygosity at miR-185
and Dgcr8 loci. Although more than one miRNA contributes,
the major effect is due to the dramatic downregulation of miR-
185. Consistent with this notion and the less profound reduction
of miR-185 in Dgcr8+/mice (Figure 1E), 2310044H10Rik is only
modestly upregulated in this strain (Figure S3A). Interestingly,
a comparison between the 30 UTR of human and mouse ortho-
logs (Figure 3A) reveals that miR-185 cognate Site 1 as well as
one miR-485 binding site are located within a highly conserved
region, suggesting that these sites are critical in regulating the
levels of the human ortholog (C19orf63). Consistent with this
expectation, introduction of pre-mir-185 into human 293T cells
resulted in a significant decrease of endogenousC19orf63 levels
(Figure S3C). In addition, similar to the pattern observed in the
mouse brain, expression of C19orf63 decreases in infant brain
as depicted in BrainSpan database (http://www.brainspan.org).
It is noteworthy that inspection of our gene expression data
set as well as qRT-PCR analysis of a sample of eight high-likeli-
hood miR-185 targets identified by more than one prediction
program did not reveal any additional significant changes of
transcript levels in the brains of Df(16)A+/ mice (Figure S3D).
Furthermore, unlike 2310044H10Rik, none of the other top upre-
gulated protein-coding genes (shown in Figure 2B) are consis-
tently altered in both HPC and frontal cortex of E17, P6, and adult
Df(16)A+/ mice, and only one of them (B3gat1, see below) is
predicted to contain miR-185 seed sites in its 30 UTR. Overall,
although additional downstream targets of miR-185 likely exist
(see below), our analysis suggests that 2310044H10Rik re-
presents the major downstream effector of miR-185 and a
major hub target of miRNA dysregulation due to the 22q11.2
microdeletion. Due to confirmed miRNA-mediated regulation,
we renamed the gene Mirta22 (miRNA target of the 22q11.2
microdeletion).
Mirta22 Encodes a Neuronal Protein Residing
in the Golgi Apparatus
Mirta22 encodes a 28 kDa protein without any known sequence
homology or functional domain (http://www.uniprot.org/uniprot/
Q3TAS6). The murine ortholog is located on mouse chromo-
some 7 and contains seven coding exons. The human ortholog
(C19orf63) is located on chromosome 19q13.33 and encodes
a protein with 92.3% identity to the murine protein (Figure 4A).
One mouse reference sequence (isoform 1) is reported in Gen-
Bank, whereas two C19orf63 isoforms (isoform 1 and 2) are re-
ported in GenBank and in the literature (Junes-Gill et al., 2011).
The protein encoded by isoform 1 is predicted to contain a
N-terminal signal peptide, as well as a transmembrane segment
(Figure 4A, red rectangles), which separates a long N-terminal
region from a short C-terminal segment that contains a polygly-
cine tail with unknown function. Isoform 2 differs from isoform 1
by an alternatively spliced exon located after exon 6. The protein
encoded by isoform 2 is shorter by eight amino acids, contains
the N-terminal signal peptide but not the transmembrane
segment, and is predicted to be secreted (Figure 4A). We raised
a polyclonal antibody against a segment of the protein that is
conserved in the mouse and human orthologs (amino acids207–226, Figure 4A, green rectangle; see Extended Experi-
mental Procedures; Figure S4). We validated the specificity of
the antibody using a number of assays (see Extended Experi-
mental Procedures; Figures S4A–S4C) and showed that it can
also detect the secreted form of the protein in 293T cell cultures
(Figure S4D). Western blot assays of protein extracts from
the brain of Df(16)A+/ mice and WT littermates showed the
expected increase (25%) in Mirta22 levels in mutant mice (Fig-
ure 4B). A similar magnitude increase of the Mirta22 immunocy-
tochemical signal was observed in Df(16)A+/ cultured neurons,
as compared to WT neurons (Figure 4C).
Immunostaining of neuronal cultures showed that Mirta22 is
primarily a neuronal protein (Figure 4D, top). At the subcellular
level, it is found primarily in the soma, where it colocalizes with
the Golgi apparatus marker GM130 (Nakamura et al., 1995). As
the neurons mature, it is also found in vesicles and tubular-like
clusters within the dendritic shafts (Figure 4D, middle). Mirta22
immunoreactivity was not detected in cultures stained with pre-
immune serum (Figure S4E) and was diminished by 64% in
Mirta22 shRNA-transfected neurons (Figures S4F and S4G,
lower panel). Immunohistochemical analysis demonstrated that
Mirta22 is widely distributed in the brain, where it is localized in
neurons (Figure 4D, bottom).
miR-185 Reduction Results in Coordinated Mild
Dysregulation of Golgi-Related Genes
Accumulating evidence suggests that miRNAs may target
functionally connected genes, often in a developmental stage-
specific manner (Tsang et al., 2010; Zhang et al., 2009). Consis-
tent with this notion, functional annotation clustering analysis
of 2,695 out of 2,708 predicted miR-185 targets (TargetScan
Mouse v.5.2) included in the DAVID Mus musculus gene
functional annotation database (http://david.abcc.ncifcrf.gov)
identified as the top enriched gene cluster (gene count = 159,
Enrichment Score = 8.56, FDR-corrected p = 2 3 109) the
Gene Ontology (cellular component) term ‘‘Golgi apparatus’’
(Figure 5A). Gene set enrichment analysis (GSEA) on the 2,708
predictedmiR-185 targets ranked based on the gene expression
profile of Df(16)A+/ mice also indicated that the Gene Ontology
terms ‘‘Golgi apparatus part’’ and ‘‘Golgi apparatus’’ were
among the top 20 gene sets in the adult HPC (Figure 5A). A global
perspective on the enrichment of this miR-185 target gene set
among the differentially expressed genes in the Df(16)A+/
mice showed a significant enrichment in the adult HPC expres-
sion profile (p = 5 3 104) where, as expected, most of the top
geneswere upregulated (n = 34), and only four geneswere down-
regulated (p < 0.005, Figure 5B; Table S4). A considerably more
modest enrichment was suggested for the E17 (p = 0.02) and P6
HPC (p = 0.016) profiles (Figure S5). Interestingly, there was no
significant enrichment within the PFC profiles in any of the three
ages tested (E17: p = 0.6311; P6: p = 0.1326; adult: p = 0.244).
Expression changes were modest, with only 4 of 159 Golgi-
related probe sets included among the top 100 in the adult HPC.
Altered miR-185 Levels Contribute to Structural
Alterations of Df(16)A+/ Neurons
Df(16)A+/ mice show impaired formation of dendrites and
spines in the HPC (Mukai et al., 2008) and the PFC (FiguresCell 152, 262–275, January 17, 2013 ª2013 Elsevier Inc. 267
Figure 4. Genomic Structure, Neuronal Expression, and Subcellular Localization of 2310044H10Rik
(A) Top view shows the structure of mRNA transcripts of 2310044H10Rik (Mirta22) and its human ortholog, C19orf63. RefSeq reports a 2310044H10Rik (Mirta22)
transcript with seven exons (blue rectangles), which is predicted to encode a signal peptide and a transmembrane domain (red rectangles). The peptide epitope
used to generate a polyclonal antibody is marked by a green rectangle. For C19orf63, RefSeq reports two alternatively spliced transcripts: one that encodes
a predicted transmembrane protein and one with an additional exon that encodes a predicted secreted protein. Bottom view shows protein sequence alignment
of predicted transmembrane isoforms encoded by 2310044H10Rik (Mirta22) and its human ortholog. Black blocks indicate completely conserved residues, gray
blocks indicate similar residues (defined by Boxshade default similarities), and white blocks indicate different residues.
(B) Upper view presents representative western blot assays of 2310044H10Rik (Mirta22) in PFC lysates prepared from Df(16)A+/ animals and WT littermates.
a-tubulin is used as loading control. Lower view is quantification of 2310044H10Rik (Mirta22) protein level in PFC of Df(16)A+/ and WT animals (n = 9 each
genotype). Expression levels in mutant mice were normalized to WT littermates. Results are expressed as mean ±SEM. **p < 0.01 (Student’s t test).
(C) Quantification of 2310044H10Rik (Mirta22) immunocytochemical signals in Df(16)A+/ and WT cultured neurons (n = 31 for Df(16)A+/; n = 34 for WT).
Expression levels in mutant neurons were normalized to WT neurons. Results are expressed as mean ±SEM. *p < 0.05 (Student’s t test).
(D) Upper panel shows that 2310044H10Rik (Mirta22) colocalizes with neuron-specific marker NeuN, but not with glia-specific marker GFAP, in cultured
hippocampal neurons at DIV20. Middle panel shows that 2310044H10Rik (Mirta22) (green) colocalizes with Golgi-specific marker GM130 (red) in the soma.
2310044H10Rik (Mirta22) is also found in vesicles and tubular-like clusters in the dendrites,which are highlighted by the dendriticmarkerMAP2 (blue). Lower panel
presents distribution of 2310044H10Rik (Mirta22) protein in adult mouse brain. Sections were stainedwith 2310044H10Rik (Mirta22) antibody. Imageswere taken
at 43, 103, 203, and 403magnifications as indicated. Redboxes in 43, 103, and 203 images outline the area shown in 103, 203, and 403 images, respectively.
See also Figure S4.S6A–S6C), which are faithfully recapitulated in primary neuronal
cultures. Impairment in these processes inDf(16)A+/mice could
only be partially accounted for by the 50% decrease in the levels
of Dgcr8 (Fe´nelon et al., 2011; Stark et al., 2008). Localization of
Mirta22 within the Golgi apparatus and dendritic shafts suggests268 Cell 152, 262–275, January 17, 2013 ª2013 Elsevier Inc.that diminishment of the miR-185 repression on Mirta22 levels
may also contribute to these deficits.
To test this hypothesis, we first asked whether reduction of
miR-185 levels results in deficits in dendritic and spine develop-
ment similar to those observed in Df(16)A+/ neurons (Mukai
Figure 5. Coordinated Mild Dysregulation of Golgi-Related Putative miR-185 Targets in Df(16)A+/ Mice
(A) DAVID functional annotation clustering analysis (left) and GSEA (v.2.0) (right) of genes predicted as miR-185 targets by TargetScan Mouse v.5.2 identified
Gene Ontology (GO) terms ‘‘Golgi apparatus’’ and ‘‘Golgi apparatus part’’ as the top enriched gene sets (see Extended Experimental Procedures).
(B) Expression heatmap plot of the potential miR-185 targets that serve Golgi apparatus-related functions (GO term) and are differentially expressed (p < 0.005)
between adult HPC of Df(16)A+/ mice and WT littermates. ID, Affymetrix ID (see Table S4); Rank, the ranking position in the list of all differentially expressed
genes according to significance level. Note that the majority (89%, 34 out of 38) of the genes are upregulated.
See also Figure S5 and Table S4.et al., 2008). We introduced an anti-miR-185 and a scramble
control LNA oligo into WT primary hippocampal neurons and
measured dendritic and spine morphology 2 days posttrans-
fection at DIV9 and DIV19, respectively. Analysis of dendritic
architecture indicated that reduction of miR-185 levels leads to
deficits in dendritic complexity (Figure 6A), including a significant
reduction in the number of primary dendrites (21%, p < 0.05; Fig-
ure 6B) and a significant reduction in total branchpoints in trans-
fected neurons (16%, p < 0.05; Figure 6C). This finding was
confirmed by Sholl analysis, which compares branchpoint
numbers at varying distances from the soma (Figure S6D). More-
over, reduction of miR-185 levels in DIV19 neurons results in
decreased spine density (21%, p < 0.05; Figures 6D, 6E, and
S6E) and a significant reduction in their median width (15%
decrease, p < 0.001, Kolmogorov-Smirnov test; Figure 6F).
Consistently, introduction of pre-mir-185 mimic into WT neurons
increased the number of primary dendrites, number of branch-points, density, and head width of mushroom spines (Figures
S6F and S6G).
We also examined whether elevation of miR-185 levels could,
at least partially, reverse cytoarchitectural alterations observed
in Df(16)A+/ neurons (Mukai et al., 2008). We transfected
primary hippocampal neurons from Df(16)A+/ mice and their
WT littermates with pre-mir-185 or prescramble. A cotransfected
GFP reporter plasmid allowed us to analyze the dendritic archi-
tecture (Figures 6G–6I) and spine morphology (Figures 6J–6L)
of pyramidal neurons 2 days posttransfection at DIV9 and
DIV19, respectively. Consistent with previous results (Mukai
et al., 2008), compared toWT neurons,Df(16)A+/ neurons trans-
fected with prescramble showed reduced dendritic complexity
as manifested by a decrease in the number of primary dendrites
(25%, p < 1010; Figure 6H) and number of dendritic branch-
points (38%, p < 104; Figure 6I). They also showed reduced
spine density (38%, p < 106; Figure 6K) as well as a small butCell 152, 262–275, January 17, 2013 ª2013 Elsevier Inc. 269
Figure 6. Reduced miR-185 Levels Contribute to Structural Alterations of Df(16)A+/ Neurons
(A) Representative images of WT neurons at DIV9 transfected with anti-miR control or anti-miR-185 oligos and enhanced GFP.
(B and C) Reduction in the number of primary dendrites (B) and branchpoints (C) in WT neurons at DIV9, 2 days after transfection with anti-miR-185 relative to
WT neurons transfected with anti-miR control (n = 21 forWT + anti-miR-185; n = 20 forWT + anti-miR control). In (C), values ofWT + anti-miR-185were normalized
to WT + anti-miR control.
(D) Representative images of spines on WT neurons at DIV19, transfected with anti-miR control or anti-miR-185, as well as enhanced GFP.
(E) Reduction in the density of mushroom spines in neurons transfected with anti-miR-185 relative to neurons transfected with anti-miR control (n = 20 for WT +
anti-miR-185; n = 20 for WT + anti-miR control). Values of WT + anti-miR-185 were normalized to WT + anti-miR control.
(F) Transfection of anti-miR-185 oligos significantly decreased the width of mushroom spines compared to that of the neurons transfected with anti-miR control
at DIV19 (15%, p < 0.001, Kolmogorov-Smirnov test) (n = 232 for WT + anti-miR-185; n = 293 for WT + anti-miR control).
(G) Representative Df(16)A+/ neurons at DIV9 transfected with prescramble or pre-mir-185 mimic and enhanced GFP for visualization. Scale Bar, 20 mm.
(H and I) Reduction in the number of primary dendrites (H) and branchpoints (I) inDf(16)A+/ neurons at DIV9 relative toWT neurons is reversed by the transfection
of pre-mir-185, but not prescramble mimic (pre-scr) (n = 21 for WT + pre-scr; n = 21 for Df(16)A+/ + pre-scr; n = 21 for Df(16)A+/ + pre-mir-185). In (I), values of
Df(16)A+/ neurons were normalized to WT + pre-scr.
(J) Representative images of spines on Df(16)A+/ neurons at DIV19, transfected with prescramble or pre-mir-185 mimic, as well as enhanced GFP. Scale Bar,
5 mm.
(legend continued on next page)
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statistically significant decrease in median head width (8%
decrease, p < 0.01; Figure 6L) of mushroom spines. Increase in
miR-185 activity largely reversed the deficits in dendritic
complexity (Figures 6H, 6I, and S6H) and the reduction in
spine density (Figures 6K and S6I) and increased the head
width of mushroom spines in Df(16)A+/ hippocampal neurons
(Figure 6L).
Elevation of Mirta22 Levels Inhibits Dendritic and Spine
Development in Df(16)A+/ Neurons
We examined whether elevation of Mirta22 levels could partially
phenocopy the structural alterations observed in Df(16)A+/
neurons (Mukai et al., 2008). We introduced a Mirta22 cDNA
into WT primary hippocampal neurons and measured dendritic
and spine morphology 2 days posttransfection, at DIV9 and
DIV19, respectively. Control experiments using qRT-PCR and
western blot confirmed that the Mirta22-encoding plasmid
drives increased expression of Mirta22 at both mRNA and
protein levels (Figures S7A and S7B). Analysis of dendritic archi-
tecture indicated that elevation of Mirta22 levels results in
a significant reduction in the number of primary dendrites
(18%, p < 0.001; Figure S7C) and total branchpoints in trans-
fected neurons (41%, p < 105; Figure S7D). This finding was
confirmed by Sholl analysis (Figure S7E). Moreover, elevation
of Mirta22 levels in DIV19 neurons results in decreased spine
density (22%, p < 0.05; Figure S7F) and a small but significant
reduction in the mushroom spine median width (8% decrease,
p < 0.001, Kolmogorov-Smirnov test; Figure S7G). These struc-
tural deficits recapitulate those observed in Df(16)A+/ neurons,
suggesting that these deficits are, at least in part, due to the
aberrantly high levels of Mirta22.
We also asked whether reduction of Mirta22 levels could, at
least partially, reverse cytoarchitectural alterations observed in
Df(16)A+/ neurons (Mukai et al., 2008). We transfected primary
hippocampal neurons isolated from Df(16)A+/ embryos and
their WT littermates with constructs that coexpress turbo RFP
(tRFP) and either a shRNA engineered to knock down expres-
sion of endogenous mouse Mirta22 or a scramble control
shRNA (scr shRNA). We confirmed that the Mirta22 shRNA
can effectively knock down the expression of Mirta22 at both
mRNA and protein levels (Figures S7H and S7I). We analyzed
dendritic architecture and spine morphology 2 days following
transfection, at DIV9 and DIV19, respectively. Introduction of
Mirta22 shRNA restored to WT levels the number of primary
dendrites of Df(16)A+/ neurons at DIV9 (Mirta22 shRNA versus
scr shRNA, 40% increase, p < 105; Figure 7A). A trend for
increase in the total number of branchpoints in Df(16)A+/
neurons was also observed (25% increase, p = 0.16; Figure S7J).
Sholl analysis confirmed that introduction of Mirta22 shRNA in
Df(16)A+/ neurons increased branchpoint numbers mainly in(K) Reduction in the density of mushroom spines in DIV19Df(16)A+/ neurons relat
prescramble mimic, into Df(16)A+/ neurons (n = 23 for WT + pre-scr; n = 21 for D
neurons were normalized to WT + pre-scr.
(L) Transfection of pre-mir-185 mimic, but not prescramble control, significantly i
p < 0.001, Kolmogorov-Smirnov test) (n = 568 for WT + pre-scr; n = 339 for Df(1
Results for (B), (C), (E), (H), (I), and (K) are expressed as mean ±SEM. *p < 0.05,the proximal dendritic segments from the soma (Figure S7K).
Furthermore, whereas DIV19 Df(16)A+/ neurons transfected
with the control shRNA had fewer and thinner mushroom spines
than WT neurons, introduction ofMirta22 shRNA into Df(16)A+/
neurons reversed the deficit in density (Mirta22 shRNA versus
scr shRNA, 91% increase, p < 106; Figure 7B), whereas it
had no significant impact on spine width (Figure 7C). The obser-
vation that reduction of Mirta22 levels partially reverses the
structural deficits observed in Df(16)A+/ mice was confirmed
by using an independent Mirta22 shRNA (Figures S7L–S7N)
and strongly suggests that Mirta22 acts as an inhibitor mediating
the effects of the structural mutation of dendritic and spine
growth.
Reduction of Mirta22 Levels Reverses Structural
Alterations in the HPC of Df(16)A+/ Mice
To determine whether Mirta22 plays a role in vivo, we asked
whether reduction of Mirta22 levels reverses previously
reported deficits in dendritic and spine formation at hippo-
campal CA1 pyramidal neurons of Df(16)A+/ mice (Mukai
et al., 2008). To this end, we used Mirta22 mutant mice
(2310044H10RikGt(OST181617)Lex/Mmucd) carrying a retroviral
gene trap insertion into intron 1 (Figure 7D). We confirmed that
the insertion results in drastic reduction of Mirta22 transcript
and protein levels in the HPC of mutant mice (Figures 7E and
7F). We then crossed this line with Df(16)A+/ mice to generate
mice compound heterozygous for theDf(16)A andMirta22muta-
tions (Df(16)A+/;Mirta22+/). Double mutants were compared to
single mutants, as well as WT littermates, to evaluate the contri-
bution ofMirta22 upregulation to the dendritic and spine pheno-
types induced by Df(16)A. We used diolistics to sparsely label
individual HPC neuronswith DiI and analyzed dendritic and spine
morphology in the CA1 subfield of all four genotypes using
confocal imaging.
Our analysis confirms previously reported alterations in
complexity and spine formation at the basal dendritic tree of
CA1 pyramidal neurons of Df(16)A+/ mice. Moreover, we
show that the presence of the Mirta22 mutation in compound
heterozygous Df(16)A+/;Mirta22+/ mice reverses to WT levels
the number of primary dendrites and total number of branch-
points (Figures 7G–7I). Sholl analysis confirmed that reduction
ofMirta22 levels in Df(16)A+/mice results in increased dendritic
branchpoint numbers (Figure 7J). Importantly, Mirta22+/ mice
did not differ significantly fromWT littermates in any of the tested
parameters. Similarly, the presence of the Mirta22 mutation in
compound heterozygous Df(16)A+/;Mirta22+/ mice reversed
to almost WT levels the Df(16)A-induced deficit in density and
size of spines at the basal dendrites of CA1 neurons (Figures
7K–7M). Mirta22+/ mutants did not differ significantly from WT
littermates in these two parameters.ive toWT control neurons is reversed by the transfection of pre-mir-185, but not
f(16)A+/ + pre-scr; n = 23 for Df(16)A+/ + pre-mir-185). Values of Df(16)A+/
ncreased the width of mushroom spines of Df(16)A+/ neurons at DIV19 (18%,
6)A+/ + pre-scr; n = 527 for Df(16)A+/ + pre-mir-185).
**p < 0.01, ***p < 0.001 (Student’s t test). See also Figure S6.
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Figure 7. Reduction of Mirta22 Levels Reverses Structural Alterations in the HPC of Df(16)A+/ Mice In Vitro and In Vivo
(A) Reduction in the number of primary dendrites inDf(16)A+/ neurons at DIV9 relative toWT neurons is reversed by the transfection of a construct that expresses
2310044H10Rik (Mirta22) shRNA+/ (n = 24 for WT + scr shRNA; n = 21 for Df(16)A+/ + scr shRNA; n = 25 for Df(16)A+/ + Mirta22 shRNA).
(B) Reduction in the density of mushroom spines in Df(16)A+/ neurons at DIV19 relative to WT neurons is reversed by the introduction ofMirta22 shRNA, but not
scr shRNA (n = 22 forWT + scr shRNA; n = 24 forDf(16)A+/ + scr shRNA; n = 15 forDf(16)A+/ +Mirta22 shRNA). Values ofDf(16)A+/ neuronswere normalized to
WT + scr shRNA.
(C) Transfection ofMirta22 shRNA does not affect the width of mushroom spines of Df(16)A+/ neurons at DIV19 (p > 0.05, Kolmogorov-Smirnov test; n = 342 for
WT + pre-scr; n = 289 for Df(16)A+/ + pre-scr; n = 177 for Df(16)A+/ + pre-mir-185).
(legend continued on next page)
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DISCUSSION
Accumulating evidence suggests that miRNAs play an important
role in the pathogenesis and pathophysiology of psychiatric
disorders and cognitive dysfunction (Moreau et al., 2011; Stark
et al., 2008; Xu et al., 2010). Here, we provide a comprehensive
view of the pattern of miRNA dysregulation emerging due to
22q11.2 deletions, which is shaped by the combined effect of
miR-185 and Dgcr8 hemizygosity. In this context, our results
show a considerably greater reduction than the expected 50%
decrease in the expression of a 22q11.2 gene, indicating that
mechanisms other than simple haploinsufficiency could repre-
sent an important and previously unappreciated component of
CNV pathogenicity. Along these lines, our results also raise the
intriguing possibility that 22q11.2 microdeletions, by partially
disabling the miRNA machinery, create a sensitized genetic
background, which promotes the effects of deleterious muta-
tions that affect the expression or activity of a subset of miRNAs
(Ambros, 2010; Brenner et al., 2010).
By comparing gene expression profiles over three develop-
mental stages and three levels of genomic dosage at the
22q11.2 locus, we identified elevated levels of a previously un-
characterized gene, Mirta22, as the most robust change in
gene expression resulting from the 22q11.2 microdeletion, as
well as the major downstream transcriptional effect of the
22q11.2-associated miRNA dysregulation. Localization of
Mirta22 in the Golgi apparatus and in vesicle and tubular-like
extensions in dendrites is consistent with a role in membrane
and protein trafficking and secretion, which is necessary for
establishment and maintenance of neuronal connections (Evans
et al., 2011; Horton et al., 2005; McAllister, 2000; Rosso et al.,
2005; Wayman et al., 2006). Mirta22 is likely to act in concert
with other genes within the 22q11.2 deletion (Karayiorgou
et al., 2010), including the Zdhhc8 palmitoyl-transferase, which
is also located in the Golgi apparatus and modulates dendritic
and spine development (Mukai et al., 2008). Moreover, although
Mirta22 represents a major downstream effector of miR-185(D) Schematic (not to scale) of the genomic structure ofMirta22 depicting the gen
approximate genomic location of PCR primers used for qRT-PCR.
(E)Mirta22 transcript levels in HPC of adult homozygous (n = 3) and heterozygous
qRT-PCR.
(F) Representative western blot assay depicting Mirta22 protein levels in HPC of
mice as well as their WT littermates. Levels of a-tubulin are shown as internal loa
(G) Representative images from diolistic labeling of basal dendrites of CA1 pyramid
old littermate mice.
(Hand I)Numberofprimarydendrites (H) andbranchpoints (I) in thebasaldendritic t
forDf(16)A+/; n = 23 forDf(16)A+/;Mirta22+/; n = 22 forMirta22+/). In (I), values o
(J) Sholl analysis of basal dendrite complexity of CA1 pyramidal neurons using 1
n = 23 for Df(16)A+/;Mirta22+/; n = 22 forMirta22+/). Note that the reduction in b
from soma as compared to WT neurons (black asterisks for WT versus Df(16)A+/
asterisks for Df(16)A+/ versus Df(16)A+/;Mirta22+/ comparison).
(K) Representative images of spines at the basal dendrites of CA1 pyramidal ne
littermate mice.
(L) Density of total spines in the basal dendritic tree of CA1 pyramidal neurons fro
CA1 neurons is reversed in the compound heterozygous Df(16)A+/;Mirta22+/m
Mirta22+/).
(M)Width of mushroom spines (quantified over 60 mmof dendritic length) in the ba
that reduction in width is reversed in the compound heterozygous mice Df(16)A+
Results are expressed as mean ±SEM. *p < 0.05, **p < 0.01, ***p < 0.001 (Studedysregulation, our finding of a coordinated miR-185 targeting
of Golgi-apparatus-related genes suggests thatMirta22 upregu-
lation may act, in an age- and brain region-specific manner, in
concert with other modestly altered miR-185 targets to interfere
with the Golgi-related processes required for neuronal matura-
tion. Thus, our findings highlight a link between the Golgi appa-
ratus and neuronal phenotypes associated with the 22q11.2
microdeletion.
Mirta22 bias toward prenatal expression suggests that this
gene may play an important role in both restricting neural circuit
formation prenatally, when embryonically generated neurons are
still migrating and extending their axons, and in permitting
neuronal maturation and synaptogenesis to unfold in the
postnatal brain, after neurons have migrated to their final desti-
nations. Consistent with the notion that miRNAs function
predominantly as fine-tuning regulators of the expression levels
of their targets (Baek et al., 2008; Selbach et al., 2008), miR-185
and to a lesser extent other miRNAs affected by the 22q11.2
deletion appear to restrict and optimize Mirta22 expression,
presumably to avoid excessive inhibition during the critical stage
of postnatal synapse formation. Accordingly, sustained dere-
pression of the gene due to genomic loss at the 22q11.2 locus
may have an impact on the formation of neural circuits in early
postnatal development, as well as on their maintenance during
adulthood. Such structural changes could result in local and
long-distance disruptions of neuronal communication (Fe´nelon
et al., 2011; Sigurdsson et al., 2010), contributing to the cognitive
dysfunction, psychiatric phenotypes, or both. In agreement with
this prediction, expression of the human ortholog of Mirta22
(C19orf63) declines in infant brains (Kang et al., 2011).
It has been shown that, during the transition between human
fetal and infant development, a large number of genes reverse
their direction of expression from an increase in the first two
trimesters in utero to a decrease in the third trimester (which
corresponds to postnatal development in rodents; Clancy
et al., 2007) as well as after birth. Approximately 40% of them
are predicted miRNA targets (Colantuoni et al., 2011; Xu et al.,e trap insertion in the intron between exons 1 and 2. Red arrowheads indicate
(n = 3)Mirta22mutant mice as well as their WT littermates (n = 3), as assayed by
adult homozygous (Hom; n = 3) and heterozygous (Het; n = 3) Mirta22 mutant
ding controls.
al neurons from all four tested genotypes. Brains were dissected from 8-week-
reeofCA1pyramidal neurons fromall four testedgenotypes (n=17 forWT;n=29
fDf(16)A+/ andDf(16)A+/;Mirta22+/ neuronswere normalized toWT neurons.
0 mm concentric circles around the soma (n = 17 for WT; n = 29 for Df(16)A+/;
ranching inDf(16)A+/CA1 neurons is more prominent at the 50–100 mm range
 comparison), and it is reversed in the presence of theMirta22 mutation (blue
urons from all four tested genotypes. Brains were dissected from 8-week-old
m all four tested genotypes. Note that reduction in spine density in Df(16)A+/
ice (n = 14 for WT; n = 6 for Df(16)A+/; n = 9 for Df(16)A+/;Mirta22+/; n = 9 for
sal dendritic tree of CA1 pyramidal neurons from all four tested genotypes. Note
/;Mirta22+/ (p < 0.001, Kolmogorov-Smirnov test).
nt’s t test). See also Figure S7.
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2012). In that respect, Mirta22 is one example of a disease-
related gene representative of this type of transcriptional trajec-
tory indicative of a miRNA-imposed temporal control over the
sequential maturation of neurons, synapses, and circuits. Anal-
ysis of common variation in the vicinity of the human ortholog
(Schizophrenia Psychiatric Genome-Wide Association Study
(GWAS) Consortium, 2011) identified one SNP (rs10401266) 35
kb upstream of C19orf63 in a presumptive regulatory region
with nominally significant association with SCZ (p = 5 3 103).
The impact of rare variants in C19orf63 remains to be deter-
mined, but importantly, we recently provided evidence that
rare de novo deleterious mutations in genes showing a prenatal
expression bias and miRNA regulation similar to Mirta22 are
enriched in individuals with SCZ, especially thosewith prominent
early prepsychotic, deviant behaviors (Gilman et al., 2012; Xu
et al., 2012). Overall, understanding how Mirta22 affects
neuronal connectivity and eventually behavior and cognition is
likely to provide more general insights into the contribution of
miRNAs in psychiatric and neurodevelopmental disorders, illu-
minate the patterns of neural complexity underlying these disor-
ders, and facilitate development of new treatments.
EXPERIMENTAL PROCEDURES
Mutant Mice
All animal protocols used in this study are approved by Columbia University
IACUC. Df(16)A+/ and Dgcr8+/ mice have been described previously
(Stark et al., 2008; Mukai et al., 2008) and have been backcrossed into
C57BL/6J background for over ten generations. Mirta22 mutant mice
(2310044H10RikGt(OST181617)Lex/Mmucd, referred to as Mirta22+/) were ob-
tained from the Mutant Mouse Regional Resource Centers supported by NIH.
qRT-PCR and Expression Profiling
Total RNA was isolated by miRNeasy mini kit. qRT-PCR was performed as
described previously (Stark et al., 2008). For expression profiling, cDNA was
generated and exposed to the Affymetrix Mouse genome 430 2.0 array, which
includes 45,000 probe sets from >34,000 well-characterized mouse genes.
Data were obtained using GeneChip Analysis Software Microarray Suite
version 5 and analyzed with limma package in the Bioconductor project
(http://www.bioconductor.org). Details are provided in Extended Experimental
Procedures.
Analysis of Dendritic Complexity and Spine Morphology
Dissected E17 hippocampal neurons were plated at 2 3 105 cells/ml in 6-well
plates, cultured for 9–19 days, and transfected with GFP or RFP plasmids de-
pending on the experiment. CA1 pyramidal neurons were sparsely labeled
using diolistic labeling (see Extended Experimental Procedures). Images of
dendrites and dendritic spines were acquired as described previously by
Mukai et al. (2008). An experimenter blind to the genotype performed imaging
and analysis. Details are provided in Extended Experimental Procedures.
Luciferase Assays
Mirta22 30 UTR was cloned into psiCHECK2. Binding site mutant clones were
generated by PCR-based mutagenesis. N18 neuroblastoma cells were trans-
fected with various psiCHECK2 reporter constructs together with pre-mir-185
mimic or prescramble control unless mentioned otherwise, and luciferase
assays were performed using the Promega Dual-Luciferase Reporter Assay
System. All experiments were performed at least two times, and all data pre-
sented are the average of three technical repeats. Details are provided in
Extended Experimental Procedures.
Functional Enrichment Analysis of PredictedmiR-185 Targets
miR-185 target gene list was imported into DAVID gene functional annotation
database. Functional annotation was conducted using the program’s func-274 Cell 152, 262–275, January 17, 2013 ª2013 Elsevier Inc.tional annotation clustering analysis with default settings. GSEA was con-
ducted using GSEA v.2.0. Details are provided in Extended Experimental
Procedures.
Antibodies
A 20 amino acid peptide ([C]-CEQAQKAKNPQEQKSFFAKY-[N]) was used to
generate a rabbit polyclonal antibody. Western blot, immunohistochemistry,
and immunocytochemistry assays were conducted as previously described
(Mukai et al., 2008; Stark et al., 2008). Details are provided in Extended Exper-
imental Procedures.
ACCESSION NUMBERS
Expression profiling data are available at Gene Expression Omnibus under
accession number GSE29767.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and four tables and can be foundwith this article online at http://dx.doi.
org/10.1016/j.cell.2012.11.052.
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